BowdenMBChristieDBHandKHMontgomeryA. Crotalidae polyvalent immune fab and cost-effective management of hospital admissions for snakebites. Am Surg. 2022;88(3):31348211054566. doi:10.1177/00031348211054566.
2.
CasewellNRJacksonTNWLaustsenAHSunagarK. Causes and Consequences of snake venom variation. Trends Pharmacol Sci. 2020;41(8):570-581. doi:10.1016/j.tips.2020.05.006.
3.
Ramirez-CuevaFLarsenAKnowltonE, et al.Predictors of FabAV use in copperhead envenomation. Clin Toxicol. 2022;1:1-6. doi:10.1080/15563650.2021.2018454.
4.
DartRCHurlbutKMGarciaRBorenJ. Validation of a severity score for the assessment of crotalid snakebite. Ann Emerg Med. 1996;27(3):321-326. doi:10.1016/s0196-0644(96)70267-6.
5.
WaiddyanathaSSilvaASiribaddanaSIsbisterGK. Long-term effects of snake envenoming. Toxins. 2019;11(4):193. doi:10.3390/toxins11040193.
6.
AbouyannisMAggarwalDLallooDGCasewellNRHamalubaMEsmailH. Clinical outcomes and outcome measurement tools reported in randomised controlled trials of treatment for snakebite envenoming: A systematic review. In: HabibAG, eds, 15; 2021:e0009589. doi:10.1371/journal.pntd.0009589.
7.
GerardoCJVissociJRNEvansCSSimelDLLavonasEJ. Does this patient have a severe snake envenomation?: The rational clinical examination systematic review. JAMA Surg. 2019;154(4):346-354. doi:10.1001/jamasurg.2018.5069.